Neil Milloy
AuthID: R-00K-6B5
1
TITLE: Criteria used to determine platinum eligibility and first-line (1L) treatment (tx) patterns among platinum-eligible (PE) and -ineligible (PI) patients (pts) with metastatic urothelial cancer (mUC) in France, Germany, Spain, Italy, and the United Kingdom (Eu5).
AUTHORS: Milloy, Neil; Kirker, Melissa; Berry, Mia; Kostikas, Michael; Montgomery, Rachel; Kearney, Mairead; Costa, Nuno Matos; Chang, Jane;
PUBLISHED: 2022, SOURCE: JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 40, ISSUE: 6
AUTHORS: Milloy, Neil; Kirker, Melissa; Berry, Mia; Kostikas, Michael; Montgomery, Rachel; Kearney, Mairead; Costa, Nuno Matos; Chang, Jane;
PUBLISHED: 2022, SOURCE: JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 40, ISSUE: 6
INDEXED IN: 
WOS
WOS